Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP775240.RAjNq5GCi7g7HszELBi8aHQz9abNE-RoobTUoi6ncBfXQ130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775240.RAjNq5GCi7g7HszELBi8aHQz9abNE-RoobTUoi6ncBfXQ130_provenance.
• NP254627.RAz-UQgyuYkPOMfcMO4H92rYTV7k3cvLCxOagYOjVT1I4130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254627.RAz-UQgyuYkPOMfcMO4H92rYTV7k3cvLCxOagYOjVT1I4130_provenance.
• NP286797.RAueoCcSx1hEIdt0qIlMz3lQgHSCJ2jiCApfYNTmaNH5o130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286797.RAueoCcSx1hEIdt0qIlMz3lQgHSCJ2jiCApfYNTmaNH5o130_provenance.
• NP779545.RABwajVt2ZmgDO9C9QAB8fBYx5RcqLpORwHcbPWtNCjBI130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779545.RABwajVt2ZmgDO9C9QAB8fBYx5RcqLpORwHcbPWtNCjBI130_provenance.
• NP222863.RArPqFFLda7O85lsisAERvg5DbYLcSDdajgTOOZz5akqo130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222863.RArPqFFLda7O85lsisAERvg5DbYLcSDdajgTOOZz5akqo130_provenance.
• NP243123.RAmx_lYmSKvK7u-A4-ARsOKcTNxfzYRxHldJDl1jpxAgI130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP243123.RAmx_lYmSKvK7u-A4-ARsOKcTNxfzYRxHldJDl1jpxAgI130_provenance.
• NP899129.RAeF9LYP-Iu3qbKDnRLsQcC-6MjxBihNBU4xYeVUSrFKY130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899129.RAeF9LYP-Iu3qbKDnRLsQcC-6MjxBihNBU4xYeVUSrFKY130_provenance.
• NP561598.RA9BfbesLqwqch1EnM-eGmhzbtGObs3Fo0vZYzg7oH7YI130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561598.RA9BfbesLqwqch1EnM-eGmhzbtGObs3Fo0vZYzg7oH7YI130_provenance.
• NP564973.RA2ReWR9hGnyt-SxworfBBLzpS9krXzA03_MQ9gK4MYJ4130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564973.RA2ReWR9hGnyt-SxworfBBLzpS9krXzA03_MQ9gK4MYJ4130_provenance.
• assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP763937.RAh_OWKQ-wxClL4zJ8tTN6dAi4eEU-42DN6cLmLDIkLio130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763937.RAh_OWKQ-wxClL4zJ8tTN6dAi4eEU-42DN6cLmLDIkLio130_provenance.
• NP595429.RADr_D6C6nItMRX_2ewRav7JHF03O9hwo153-lCNBOmNg130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595429.RADr_D6C6nItMRX_2ewRav7JHF03O9hwo153-lCNBOmNg130_provenance.
• NP595430.RAa5YdvFL7cBjnQ2cXCSiNlV6yBkMaIQ54Ba8L7hy-BMw130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595430.RAa5YdvFL7cBjnQ2cXCSiNlV6yBkMaIQ54Ba8L7hy-BMw130_provenance.
• assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP406728.RAqB6QtwGEzCarGQiaJCffxebkb7uQZ_mxA6G0WHbK6Wc130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406728.RAqB6QtwGEzCarGQiaJCffxebkb7uQZ_mxA6G0WHbK6Wc130_provenance.
• NP406751.RAizL2GPHx_qJZS9MdeBGY7tH2rSmKoNULaH3DqZ07rwM130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406751.RAizL2GPHx_qJZS9MdeBGY7tH2rSmKoNULaH3DqZ07rwM130_provenance.
• NP595434.RApRR0MT7qkaelqi97OHLiQOjjljIQ6Yv63mjiN6vjwuA130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595434.RApRR0MT7qkaelqi97OHLiQOjjljIQ6Yv63mjiN6vjwuA130_provenance.
• NP406784.RAwPUHytwQvKR8axnD6B5mb_s98EJH0yTVyHdkt_AkU2c130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406784.RAwPUHytwQvKR8axnD6B5mb_s98EJH0yTVyHdkt_AkU2c130_provenance.
• NP989977.RANrHCTN3PdBiZLB5xHhBzYPm2mQ13NVizV5W0UuZ7Uwo130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP989977.RANrHCTN3PdBiZLB5xHhBzYPm2mQ13NVizV5W0UuZ7Uwo130_provenance.
• NP764150.RAEA7AFE_MSon5RTuYL1qvu3YM2C9tps5456F5Vq3rc9Q130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764150.RAEA7AFE_MSon5RTuYL1qvu3YM2C9tps5456F5Vq3rc9Q130_provenance.
• NP595433.RAEiuaykiXtm_V1WjZLbXp83VsdmkXnA84Jz4eqWTTlAw130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595433.RAEiuaykiXtm_V1WjZLbXp83VsdmkXnA84Jz4eqWTTlAw130_provenance.
• NP764031.RA8pvwGYbnhjbReW6DFDhDVs6ndG_2v5mMYvMWvthSIOw130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764031.RA8pvwGYbnhjbReW6DFDhDVs6ndG_2v5mMYvMWvthSIOw130_provenance.
• NP989927.RA2fFdtQc_usuOzu3uDqk1qhBKQBfdpjEVQD87AFAuyyM130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP989927.RA2fFdtQc_usuOzu3uDqk1qhBKQBfdpjEVQD87AFAuyyM130_provenance.
• NP989945.RA3U9TX3X8s-sc49AfCeg5kdnPY1NVpPrpGEL0EPTvywg130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP989945.RA3U9TX3X8s-sc49AfCeg5kdnPY1NVpPrpGEL0EPTvywg130_provenance.
• NP595431.RA477ZTo0oNqX7_rWDgeE2MCBWiLvAwIUkg1DqyoFETG4130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595431.RA477ZTo0oNqX7_rWDgeE2MCBWiLvAwIUkg1DqyoFETG4130_provenance.
• NP595432.RA9yzBpcEoLUIJXWk1LGiI7onuM2SCuxOB86w0JAKfgxU130_assertion description "[The presence of tyrosinase or MelanA/MART1 transcripts is an independent prognostic factor in patients with high-risk primary uveal melanoma for subsequent development of metastases and for survival and can be used to select patients for adjuvant treatment studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595432.RA9yzBpcEoLUIJXWk1LGiI7onuM2SCuxOB86w0JAKfgxU130_provenance.